Aethlon Medical ( (AEMD) ) just unveiled an announcement.
During the virtual Annual Meeting on September 27, 2024, shareholders of the Company made several key decisions. They elected five directors to serve until the next annual meeting, ratified the appointment of Haskell & White LLP as the independent auditor for the upcoming fiscal year, and approved both the amendment to the Plan and the compensation for the Company’s executive officers. Additionally, they authorized the potential adjournment of the meeting if needed to secure additional votes, although this was not required as all proposals passed.
Learn more about AEMD stock on TipRanks’ Stock Analysis page.
